Prevalence, persistence, clearance and risk factors for HPV infection in rural Uyghur women in China
- PMID: 37582764
- PMCID: PMC10426228
- DOI: 10.1186/s12905-023-02558-y
Prevalence, persistence, clearance and risk factors for HPV infection in rural Uyghur women in China
Abstract
Background: The incidence of cervical cancer in Uyghur women ranks first among those in Han and other ethnic minority groups. We aimed to understand the natural history of HPV in Uyghur women.
Methods: A longitudinal cohort study on the natural history of HPV infection in rural Uyghur women in China was conducted between May 2013 and May 2014. A total of 11000 women from South Xinjiang underwent HPV screening by careHPV and liquid-based cytology. Ultimately, a total of 298 women with positive HPV and normal biopsy results or CIN1 were enrolled to participate in a study including follow-up HPV testing for two years.
Results: The HPV infection rate in Uyghur women was 9.15%. Among the participants, the careHPV test showed that 298 women were HPV-positive, and histology showed CIN1 or normal results for these women at baseline. Among these patients, after 24 months of initial recruitment, 92 (30.87%) patients had persistent HPV infections, and 206 (69.13%) had cleared HPV infection. Univariate analysis showed that persistent HPV infection was associated with age and shower frequency (P < 0.001 and P = 0.047, respectively).
Conclusions: Our results suggest that women over the age of 50 years who have been infected with HR-HPV for more than 1 year should be regularly screened and monitored for HPV. In addition, education should be strengthened to improve poor health habits in these women.
Keywords: HPV; Persistent infection; Prevalence; Risk factor; Uyghur women.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women.Oncologist. 2016 Jul;21(7):825-31. doi: 10.1634/theoncologist.2015-0447. Epub 2016 Jun 17. Oncologist. 2016. PMID: 27317575 Free PMC article.
-
At what age should the Uyghur minority initiate cervical cancer screening if screened using careHPV.Cancer Med. 2021 Dec;10(24):9022-9029. doi: 10.1002/cam4.4409. Epub 2021 Nov 24. Cancer Med. 2021. PMID: 34816621 Free PMC article.
-
Prognosis and related factors of HPV infections in postmenopausal Uyghur women.J Obstet Gynaecol. 2018 Oct;38(7):1010-1014. doi: 10.1080/01443615.2018.1440285. Epub 2018 Mar 25. J Obstet Gynaecol. 2018. PMID: 29575971
-
[Real-world research on cervical cancer screening program and effect evaluation for Chinese population].Zhonghua Zhong Liu Za Zhi. 2018 Oct 23;40(10):764-771. doi: 10.3760/cma.j.issn.0253-3766.2018.10.008. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30392341 Chinese.
-
Knowledge and attitude of Uyghur women in Xinjiang province of China related to the prevention and early detection of cervical cancer.World J Surg Oncol. 2015 Mar 14;13:110. doi: 10.1186/s12957-015-0531-8. World J Surg Oncol. 2015. PMID: 25885660 Free PMC article.
Cited by
-
Unraveling HPV-associated cancer complexity: From molecular insights to innovative therapies.Heliyon. 2025 Feb 3;11(3):e42437. doi: 10.1016/j.heliyon.2025.e42437. eCollection 2025 Feb 15. Heliyon. 2025. PMID: 40007779 Free PMC article. Review.
-
Persistence and clearance rates of human papillomaviruses in a cohort of women treated or not treated for cervical dysplasia in northwest Ethiopia.Sci Rep. 2025 Mar 10;15(1):8218. doi: 10.1038/s41598-025-87568-6. Sci Rep. 2025. PMID: 40064999 Free PMC article.
-
A Comprehensive Integration of Data Regarding the Correlation of TNF-α rs1800629 Polymorphism with Susceptibility to Cervical Cancer.Asian Pac J Cancer Prev. 2024 Apr 1;25(4):1155-1167. doi: 10.31557/APJCP.2024.25.4.1155. Asian Pac J Cancer Prev. 2024. PMID: 38679974 Free PMC article.
References
-
- Bharti AC, Singh T, Bhat A, Pande D, Jadli M. Therapeutic startegies for human papillomavirus infection and associated cancers. FrontBiosci. 2018;10:15–73. - PubMed
-
- Peng YH, Lalei S, Zhou K, Wang ZH, Fang XZ, et al. Clinical analysis of cervical cancer cases. Chinese J Obstet Gynecol. 2003;38:764–5.